Apoptosis as a therapeutic paradigm in inflammatory bowel diseases

被引:0
|
作者
Verstege, Marleen I.
Velde, Anje A. te
Hommes, Daan W.
机构
[1] Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands
[2] Leiden Univ, Med Ctr, Dept Gastroenterol & Hepatol, Leiden, Netherlands
来源
ACTA GASTRO-ENTEROLOGICA BELGICA | 2006年 / 69卷 / 04期
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Evidence is increasing that a defect in apoptosis is involved in the pathogenesis of inflammatory bowel diseases (1131)), including Crohn's disease (CD) and ulcerative colitis (UC). CD seems to be the cause of an intrinsic defect in the apoptotic pathway of (autoreactive) T cells, resulting in excessive T cell responses. In UC, an increased rate of apoptosis of epithelial cells is observed. In this review we will describe apoptotic mechanisms and their association to IBD. In addition, we will review how specific therapeutic approaches interact at different levels with the apoptotic pathway.
引用
收藏
页码:406 / 412
页数:9
相关论文
共 50 条
  • [31] Combined therapeutic approach:Inflammatory bowel diseases and peripheral or axial arthritis
    Fabiola Atzeni
    Sandro Ardizzone
    Luca Bertani
    Marco Antivalle
    Alberto Batticciotto
    Piercarlo Sarzi-Puttini
    World Journal of Gastroenterology, 2009, 15 (20) : 2469 - 2471
  • [32] Network Approaches to Uncover Pathogenesis and Therapeutic Targets of Inflammatory Bowel Diseases
    Mikami, Yohei
    Kanai, Takanori
    KEIO JOURNAL OF MEDICINE, 2023, 72 (02): : 29 - 43
  • [33] FREE-RADICALS IN INFLAMMATORY BOWEL DISEASES PATHOPHYSIOLOGY AND THERAPEUTIC IMPLICATIONS
    GROSS, V
    ARNDT, H
    ANDUS, T
    PALITZSCH, KD
    SCHOLMERICH, J
    HEPATO-GASTROENTEROLOGY, 1994, 41 (04) : 320 - 327
  • [34] Combined therapeutic approach: Inflammatory bowel diseases and peripheral or axial arthritis
    Atzeni, Fabiola
    Ardizzone, Sandro
    Bertani, Luca
    Antivalle, Marco
    Batticciotto, Alberto
    Sarzi-Puttini, Piercarlo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (20) : 2469 - 2471
  • [35] Infliximab desensitization in patients with Inflammatory Bowel Diseases: a safe therapeutic alternative
    Hammoudi, N.
    Hassid, D.
    Bonnet, J.
    Minh, M. L. Tran
    Baudry, C.
    Chedouba, L.
    Vauthier, A.
    Gornet, J. M.
    Allez, M.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 643 - 643
  • [36] Inflammatory bowel diseases - 2. Current and future therapeutic options
    Moses, PL
    Moore, BR
    Ferrentino, N
    Bensen, SP
    Vecchio, JA
    POSTGRADUATE MEDICINE, 1998, 103 (05) : 86 - +
  • [37] The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity
    Alhouayek, Mireille
    Muccioli, Giulio G.
    TRENDS IN MOLECULAR MEDICINE, 2012, 18 (10) : 615 - 625
  • [38] Multi-utility of therapeutic drug monitoring in inflammatory bowel diseases
    Martins, Camilla de Almeida
    Garcia, Karoline Soares
    Queiroz, Natalia Sousa Freita
    FRONTIERS IN MEDICINE, 2022, 9
  • [39] Extracellular Vesicles: Novel Potential Therapeutic Agents in Inflammatory Bowel Diseases
    Mignini, Irene
    Piccirilli, Giulia
    Termite, Fabrizio
    Paratore, Mattia
    Esposto, Giorgio
    Laterza, Lucrezia
    Scaldaferri, Franco
    Ainora, Maria Elena
    Gasbarrini, Antonio
    Zocco, Maria Assunta
    CELLS, 2024, 13 (01)
  • [40] Connecting inflammatory bowel and neurodegenerative diseases: microRNAs as a shared therapeutic intervention
    Monaghan, Tanya M.
    Ugun-Klusek, Aslihan
    Finelli, Mattea
    Gurnani, Pratik
    Chakrabarti, Lisa
    Kao, Dina
    Alexander, Cameron
    Polytarchou, Christos
    GUT, 2024, 73 (06) : 1034 - 1036